3.84
-0.04(-1.03%)
Currency In USD
| Previous Close | 3.88 |
| Open | 3.91 |
| Day High | 4.21 |
| Day Low | 3.74 |
| 52-Week High | 10.16 |
| 52-Week Low | 1.92 |
| Volume | 21,613 |
| Average Volume | 88,104 |
| Market Cap | 9.78M |
| PE | -1.78 |
| EPS | -2.16 |
| Moving Average 50 Days | 5.01 |
| Moving Average 200 Days | 3.5 |
| Change | -0.04 |
If you invested $1000 in Biomerica, Inc. (BMRA) 10 years ago, it would be worth $545.45 as of April 29, 2025 at a share price of $3.84. Whereas If you bought $1000 worth of Biomerica, Inc. (BMRA) shares 5 years ago, it would be worth $63.16 as of April 29, 2025 at a share price of $3.84.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Detection of H. pylori Infection
GlobeNewswire Inc.
Apr 23, 2025 12:19 PM GMT
10-minute test enables detection of Helicobacter pylori, a leading cause of peptic ulcers, dyspepsia, and gastric cancerApproximately 80% of gastric cancer cases are linked to H. pylori infection; WHO classifies H. pylori as a Class 1 carcinogenThis
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Disease Test for Early Detection of Kidney Damage
GlobeNewswire Inc.
Apr 17, 2025 12:19 PM GMT
Regulatory milestone enables commercial expansion into high-need international market10-minute test detects early signs of kidney damage using a simple urine sample Addresses global public health burden of Chronic Kidney Disease (CKD), with high rele
Biomerica Announces Reverse Stock Split
GlobeNewswire Inc.
Apr 16, 2025 1:00 PM GMT
Shares Expected to Begin Trading on Split-Adjusted Basis on April 21, 2025IRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) (“Biomerica”), a global provider of advanced medical products, today announced that it will